Fidelity Moneybuilder Balanced A Inc

Ranked 68 out of 395 in - Balanced GBP over 12 months
All calculations are in GBP unless stated

Managed by

Michael Clark

Michael Clark has been working in investment management for well over two decades. An economics graduate from Cambridge University, he started out working as an analyst for Morgan Grenfell in 1986. After a two year stint he joined Enskilda where he worked until 1994 before joining JP Morgan. He then joined Fidelity International in 2002 where he runs a number of Fidelity funds including the Fidelity Enhanced Income and the Fidelity MoneyBuilder Dividend.

Sajiv Vaid

Sajiv Vaid currently works for Fidelity as a co-manager on a number of Income funds alongside Ian Spreadbury. He was formerly the co-manager on the Royal London Corporate Bond. Vaid began his career as a trainee fund manager at Capel Cure Myers in 1994, and moved on to Fuji Investment Management three years later to manage fixed income funds. Born in India in March 1969, Vaid was educated in the UK and began his career armed with a bachelor’s degree in economic and social history from the University of Hull and a master’s degree in modern international studies from the University of Leeds. His interests include cricket and current affairs.

Objective

The Fund's investment objective is to achieve an attractive level of income together with some long term capital growth from a portfolio invested primarily in the UK. The portfolio will be invested in a combination of UK government and corporate bonds and other fixed interest securities, preference shares, convertibles and ordinary shares or may achieve exposure indirectly through the use of Derivatives.

Showing fund performance in United Kingdom View performance globally

Performance

Balanced GBP over : 28/02/2018 - 28/02/2019

Total Return

Quarterly Performance

to 01/01/2019 Annual Q1 Q2 Q3 Q4
2018 -6.8% -4.7% 4.9% -0.8% -6.0%
2017 3.3% 3.8% 0.7% -1.8% 0.6%
2016 6.9% 0.6% 2.9% 5.0% -1.7%
2015 5.1% 4.6% -2.6% 0.5% 2.6%
2014 9.0% 2.5% 2.9% 0.3% 3.0%
2013 13.1% 9.3% -0.9% 1.9% 2.5%
2012 8.5% 2.2% 1.9% 3.7% 0.5%
2011 9.3% 1.3% 3.1% -0.7% 5.4%
2010 8.8% 2.7% -3.0% 7.1% 1.9%
2009 19.8% -5.7% 6.7% 14.8% 3.7%
2008 -13.6% -6.7% -5.2% -3.7% 1.5%
2007 4.8% 1.7% 2.9% -0.4% 0.6%
2006 9.6% 5.5% -2.5% 3.8% 2.6%
2005 15.7% 2.7% 3.0% 4.8% 4.3%
2004 14.0% 3.2% 1.3% 3.0% 5.8%
2003 15.6% -2.7% 10.4% 2.8% 4.7%
2002 -10.5% 4.4% -4.2% -10.4% -0.2%
2001 -0.9% -1.9% 1.5% -6.7% 6.6%
2000 5.5% -1.9% 1.5% 2.1% 3.7%
1999 4.9% 4.5% 0.1% -4.3% 4.8%
1998 17.9% 10.5% 0.7% -2.1% 8.3%
1997 21.7% 3.6% 5.1% 10.4% 1.3%
1996 12.4% 0.4% 3.4% 4.3% 3.8%
1995 11.7% -4.0% 3.6% 5.9% 6.0%
1994 -10.5% -3.9% -5.1% -0.5% -1.4%
1993 6.3% 6.6% 7.5%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/01/2019

Top 10 Holdings

Stock Size
United Kingdom 1.750% 22-Jul-2019 9.25%
United Kingdom 4.250% 07-Mar-2036 4.22%
AstraZeneca PLC ORD 3.45%
United Kingdom 5.000% 07-Mar-2025 3.28%
BP PLC ORD 3.19%
GlaxoSmithKline PLC ORD 3.10%
Royal Dutch Shell PLC ORD 3.05%
HSBC Holdings PLC ORD 2.86%
United Kingdom 4.500% 07-Dec-2042 2.71%
United Kingdom 3.250% 22-Jan-2044 2.70%
31/01/2019

Registered For Sale In

  1. France
  2. Guernsey
  3. Ireland
  4. Jersey
  5. United Kingdom

Fund Info

  • Launch date08/02/1993
  • Share Class size49Mn
  • Base currencyGBX
  • ISIN GB0003878559

Purchase Info

  • Min. initial investment50,000
  • Min. regular additional investment5,000

Charges

  • Annual management1.00%
  • Initial investment0.00%

Related News

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).